Company profile

Avalo Therapeutics

Advancing an inspired pipeline of novel IL-1β therapies focused on treating unmet medical needs.

Industry
Biotechnology
Employees
48
Headquarters
Chesterbrook, Pennsylvania
Founded
2011
LinkedIn followers
6,905
Office locations
1

Avalo Therapeutics company summary

Avalo Therapeutics is a company in the Biotechnology industry, headquartered in Chesterbrook, Pennsylvania, founded in 2011. On LinkedIn the company has around 48 employees and 6,905 followers. Its listed specialties include immunology, IL-1β, inflammation, dermatology, rheumatology.

What technology does Avalo Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Avalo Therapeutics

Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Avalo's lead asset, abdakibart, is an anti-IL-1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX-010, a long-acting next-generation anti-IL-1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.

Specialties

immunologyIL-1βinflammationdermatologyrheumatology

Where is Avalo Therapeutics located?

Avalo Therapeutics lists 1 location.

Chesterbrook, Pennsylvania, USHQ
1500 Liberty Ridge Dr

Compare companies similar to Avalo Therapeutics

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Avalo Therapeutics
avalotx.com
Biotechnology482011Chesterbrook, Pennsylvania
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Avalo Therapeutics

What does Avalo Therapeutics do?

Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Avalo's lead asset, abdakibart, is an anti-IL-1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX-010, a long-acting next-generation anti-IL-1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.

How many employees does Avalo Therapeutics have?

Avalo Therapeutics has around 48 employees on LinkedIn.

Where is Avalo Therapeutics headquartered?

Avalo Therapeutics is headquartered in Chesterbrook, Pennsylvania.

When was Avalo Therapeutics founded?

Avalo Therapeutics was founded in 2011.

Build a lead list from companies like Avalo Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.